Decheng Capital

Decheng Capital is a U.S.-based venture capital and growth equity firm focused primarily on healthcare and life sciences investments. The firm invests globally in biotechnology, pharmaceuticals, medical devices, and healthcare services companies, typically at growth and late venture stages. It supports portfolio companies with capital and strategic guidance, often working closely with management teams on clinical development, regulatory strategy, and commercialization. Decheng Capital is known for cross-border investing, particularly bridging U.S. and Asian healthcare innovation ecosystems. Its strategy emphasizes long-term value creation through backing scientifically driven companies addressing large unmet medical needs.